Coopervision

Have an extreme prescription? Thought you couldn't wear contacts?

AT A GLANCE

• Monthly replacement
• Lenses stay moist and comfortable
• Naturally wettable so you're less likely to need additional wetting drops

Extended Range May Be the Answer

Are you nearsighted or farsighted to such a degree that vision correction with contact lenses has been difficult to find? If so, CooperVision Biofinity® XR (extended range) sphere lenses may be the answer.

Biofinity XR lenses are designed for extreme prescriptions like yours. And they offer the same superior comfort and vision performance of Biofinity sphere contacts for up to six nights and seven days of continuous wear.

A Healthier Lens-Wearing Experience

Thanks to our exclusive Aquaform® Technology, Biofinity XR lenses allow plenty of oxygen to pass through to your eyes. And their natural wettability won’t rinse off. You’ll enjoy excellent vision with a soft, comfortable lens that’s healthier for your eyes.

Soak in the comfort with our multifocal contact lenses for astigmatism.

AT A GLANCE

• Monthly replacement schedule
• Correct astigmatism and presbyopia
• Stay 96% hydrated throughout the day, even after 12 hours of wear
• May help address eye dryness when wearing contact lenses

Dual Correction for Clear Vision

If you have astigmatism, you may experience blurry or distorted vision. This can happen at any age.

But somewhere between the ages of 40 to 45, everyone’s vision blurs on objects that are close up, like a book or menu. This eye condition is called “presbyopia,” and it’s part of our eyes’ normal aging process.

To clear up both conditions, you need lenses that correct your vision at any distance, like our Proclear® multifocal toric contacts. They deliver clear vision whether you’re reading the newspaper or a sign in the distance.

Naturally Resist Dryness

Thanks to our PC Technology™, water molecules actually become a part of the Proclear multifocal toric contact lens, creating a natural resistance to dryness.

In fact, Proclear contacts are the only contact lenses cleared by the U.S. FDA for the claim: "may provide improved comfort for contact lens wearers who experience mild discomfort or symptoms relating to dryness during lens wear."

The cornerstone of a comprehensive myopia management approach, MiSight® 1 day is a daily wear, single use contact lens that has been clinically proven and FDA-approved to slow the progression of myopia (nearsightedness) when initially prescribed for children 8-12 years old.

AT A GLANCE

• Suitable for children as young as 8**
• Easy for children to wear and handle
• Corrects your child’s distance vision
• Helps slow the progression of myopia (gradual prescription changes)*
• A closer look at your child's distance vision

What can you do when your child tells you they’re struggling to see the board at school? Or that things are beginning to look blurrier the further away they get from them? One cause for this blurry distance vision could be myopia. Myopia causes light rays to focus at a point in front of the retina rather than directly on the surface, owing to elongation of the eye. Myopic progression is when prescriptions increase over time, and higher prescriptions have been linked to sight-threatening conditions later in life such as retinal detachment, glaucoma and myopic maculopathy.1 

Even children with fairly low prescriptions have a higher risk of glaucoma and retinal detachment compared to non-myopic children, and that risk multiplies as their prescriptions get stronger.2

Eighty-one percent of eye care professionals agree that myopia is one of the biggest problems impacting children’s eyesight today.3 But until now, traditional eyeglasses and contact lenses available in the U.S. have only been developed to correct blurred vision, but they do nothing to help slow gradual prescription increases.

Focusing on your child's vision, now and in the future

Generally, myopia first occurs in school-age children and progresses until about age 20.4 According to the American Optometric Association, 34% of children ages 12-17 are myopic. This is due in part to changing lifestyles, with children spending less time outdoors and more time focusing on close objects like digital screens.

With FDA approval of MiSight® 1 day, CooperVision will empower eye care professionals and parents to take on pediatric myopia’s* growing prevalence and severity with a proven approach scientifically designed for the challenge.

*Indications for use.Indications for Use: MiSight® (omafilcon A) daily wear single use Soft Contact Lenses are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75  to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

**Based on a clinical study in which participants were between the ages of 8 and 12 at initial fit. 

1. Xu L, et al. High myopia and Glaucoma susceptibility for the Beijing Eye Study. Ophthalmology. 2007;114(2):216-20.  2. Bourne RR, et al. Causes of vision loss worldwide, 1990-2010: a systemic analysis. Lancet Glob Health. 2013;1(6):e339-49. 3. CooperVision data on file 2019. Myopia Awareness, The Harris Poll online survey 6/27/19 to 7/18/19 of n=313 ECPs (who see at least 1/month myopic child, age 8-15) in U.S. 4. Yu L, et al. Epidemiology, genetics and treatments for myopia. Int J Ophthalmol. 2011;4(6):658-69.